Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $144,556,539.95
- March 5, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 24, 2023 | Insider | 31,839 | $13.32 | Sell | $424,095.48 | |
Jan. 18, 2023 | Insider | 7,382 | $13.50 | Sell | $99,657.00 | |
Jan. 17, 2023 | CFO | 5,000 | $12.49 | Sell | $62,450.00 | |
Jan. 13, 2023 | Director | 15,000 | $13.03 | Sell | $195,450.00 | |
Jan. 9, 2023 | Chairman | 85,102 | $11.43 | Sell | $972,715.86 | |
Jan. 9, 2023 | CEO | 11,700 | $11.43 | Sell | $133,731.00 | |
Jan. 6, 2023 | Insider | 21,507 | $11.87 | Sell | $255,288.09 | |
Jan. 3, 2023 | Insider | 8,493 | $12.03 | Sell | $102,170.79 | |
Dec. 15, 2022 | Chairman | 10,468 | $12.15 | Sell | $127,186.20 | |
Dec. 1, 2022 | Chairman | 11,347 | $12.20 | Sell | $138,433.40 | |
Dec. 1, 2022 | CEO | 5,485 | $12.20 | Sell | $66,917.00 | |
Nov. 15, 2022 | Chairman | 10,468 | $11.64 | Sell | $121,847.52 | |
Nov. 1, 2022 | Chairman | 11,346 | $10.32 | Sell | $117,090.72 | |
Nov. 1, 2022 | CEO | 5,470 | $10.01 | Sell | $54,754.70 | |
Oct. 17, 2022 | Chairman | 10,468 | $10.90 | Sell | $114,101.20 | |
Oct. 3, 2022 | CEO | 5,470 | $10.53 | Sell | $57,599.10 | |
Oct. 3, 2022 | Chairman | 11,346 | $10.75 | Sell | $121,969.50 | |
Sept. 15, 2022 | Chairman | 10,468 | $10.66 | Sell | $111,588.88 | |
Aug. 1, 2022 | Chairman | 11,346 | $9.96 | Sell | $113,006.16 | |
Aug. 1, 2022 | Insider | 11,123 | $10.02 | Sell | $111,452.46 | |
Aug. 1, 2022 | CEO | 5,470 | $10.03 | Sell | $54,864.10 | |
July 15, 2022 | CEO | 10,468 | $10.86 | Sell | $113,682.48 | |
July 1, 2022 | COO | 5,470 | $10.72 | Sell | $58,638.40 | |
July 1, 2022 | CEO | 11,346 | $10.78 | Sell | $122,309.88 | |
June 21, 2022 | Insider | 11,122 | $10.00 | Sell | $111,220.00 | |
June 21, 2022 | COO | 16,410 | $10.00 | Sell | $164,100.00 | |
June 17, 2022 | CFO | 4,396 | $9.00 | Sell | $39,564.00 | |
June 15, 2022 | CEO | 10,468 | $8.01 | Sell | $83,848.68 | |
June 3, 2022 | CEO | 11,346 | $8.00 | Sell | $90,768.00 | |
May 23, 2022 | CEO | 21,814 | $8.00 | Sell | $174,512.00 | |
May 2, 2022 | Director | 15,000 | $6.99 | Sell | $104,850.00 | |
April 18, 2022 | CEO | 2,214 | $8.04 | Sell | $17,800.56 | |
April 7, 2022 | Insider | 11,018 | $9.06 | Sell | $99,823.08 | |
March 18, 2022 | COO | 10,940 | $10.00 | Sell | $109,400.00 | |
Jan. 18, 2022 | CEO | 8,564 | $10.23 | Sell | $87,609.72 | |
Jan. 5, 2022 | CEO | 63,543 | $12.18 | Sell | $773,953.74 | |
Jan. 3, 2022 | COO | 5,470 | $11.86 | Sell | $64,874.20 | |
Dec. 22, 2021 | COO | 3,000 | $11.70 | Sell | $35,100.00 | |
Dec. 1, 2021 | COO | 10,515 | $11.00 | Sell | $115,665.00 | |
Nov. 15, 2021 | CEO | 24,935 | $11.75 | Sell | $292,986.25 | |
Nov. 3, 2021 | CEO | 27,739 | $12.00 | Sell | $332,868.00 | |
Nov. 1, 2021 | Director | 1,500 | $10.49 | Buy | $15,735.00 | |
Nov. 1, 2021 | CEO | 7,819 | $10.80 | Sell | $84,445.20 | |
Nov. 1, 2021 | COO | 10,515 | $11.32 | Sell | $119,029.80 | |
Oct. 15, 2021 | CEO | 22,000 | $11.22 | Sell | $246,840.00 | |
Oct. 1, 2021 | Director | 1,500 | $9.56 | Buy | $14,340.00 | |
Oct. 1, 2021 | COO | 10,515 | $10.00 | Sell | $105,150.00 | |
Oct. 1, 2021 | CEO | 7,500 | $10.00 | Sell | $75,000.00 | |
Sept. 15, 2021 | CEO | 22,000 | $11.08 | Sell | $243,760.00 | |
Sept. 3, 2021 | CEO | 5,238 | $12.02 | Sell | $62,960.76 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on March 5, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.